ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

ScanWatch - The Most Advanced Hybrid Smartwatch from Withings Becomes Commercially Available Across America

November 9, 2021 GMT
Withings ScanWatch
1 of 2
Withings ScanWatch
1 of 2
Withings ScanWatch

ISSY-LES-MOULINEAUX, France, Nov. 9, 2021 /PRNewswire/ -- Today, Withings, pioneers of the connected health revolution, begins U.S. sales of ScanWatch, its award-winning and most advanced health wearable to date.

Available from Withings.com, Amazon, and Best Buy Stores, from November 9, its state-of-the-art technology has the potential to help users lead healthier lives with the ability to monitor heart rate, atrial fibrillation through ECG, blood oxygen levels through SpO2, sleep, and physical activity.

ScanWatch has been FDA cleared to both record ECG and SpO2 measurements. Developed with cardiologists and sleep experts, ScanWatch has been validated in two clinical studies and is designed with a stainless-steel case and durable sapphire glass watch face that combines both analog hands as well as a large digital display. Priced at $279 (38mm) and $299 (42 mm), it comes in a choice of black or white faces and a host of medical monitoring and health tracking capacities.

ADVERTISEMENT

These include:

  • Clinically validated detection of atrial fibrillation by ECG
  • Heart Rate scan every 10 minutes using a PPG sensor
  • Clinically validated SpO2
  • Automatic activity tracking (walking, running, swimming, distance, and calories burned)
  • Training mode with up to 30 activities (measurement of distance, pace, and altitude)
  • Fitness level assessment with VO2 Max
  • Sleep monitoring (length, quality, sleep phases)
  • Smart smartphone notifications
  • Altimeter records floors traveled
  • Water resistant up to 5 ATM
  • Up to 30 days battery life

“ScanWatch received three CES Innovation Awards when it was announced and we are now thrilled to bring it to the United States following FDA clearance” said Mathieu Letombe, CEO of Withings. “At Withings our core mission is to create beautiful devices people choose to use and wear every day so the medical and wellness data they provide can make meaningful impacts on their lives. ScanWatch has been clinically validated to detect AFib. It is our most ambitious watch to date and has the potential to help millions of people track medical and wellness data.”

For further information please visit the ScanWatch page at www.withings.com

ADVERTISEMENT

About Withings
Established in 2008, Withings, is a world leader in connected health technology. Its team of engineers, data scientists, and healthcare professionals have enthused every day, elegant lifestyle objects with medical and wellness capabilities to efficiently track health vitals. Its range of in-home devices can monitor more than 20 health and wellness parameters and are used daily by millions of people worldwide. Its portfolio of devices that includes connected scales, hybrid watches, smart thermometers, blood pressure monitors, and sleep trackers empower individuals to take back control of their health and track medical and wellness data.

Withings Media Contacts:
iantwinn@tandemcomms.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/scanwatch---the-most-advanced-hybrid-smartwatch-from-withings-becomes-commercially-available-across-america-301420003.html

SOURCE Withings